BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 22652826)

  • 21. Cushing's syndrome: Overview of clinical presentation, diagnostic tools and complications.
    Barbot M; Zilio M; Scaroni C
    Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101380. PubMed ID: 32165101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In what clinical settings should Cushing's syndrome be suspected?
    Bruno OD; Juárez-Allen L; Rossi MA; Longobardi V
    Medicina (B Aires); 2009; 69(6):674-80. PubMed ID: 20053613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcome of subclinical Cushing's syndrome after surgical and conservative treatment.
    Akaza I; Yoshimoto T; Iwashima F; Nakayama C; Doi M; Izumiyama H; Hirata Y
    Hypertens Res; 2011 Oct; 34(10):1111-5. PubMed ID: 21775997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of Cushing's Syndrome After Bariatric Surgery: Multicenter Series of 16 Patients.
    Javorsky BR; Carroll TB; Tritos NA; Salvatori R; Heaney AP; Fleseriu M; Biller BM; Findling JW
    Obes Surg; 2015 Dec; 25(12):2306-13. PubMed ID: 25917980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Management of hypercortisolism].
    Rosales C; Fierrard H; Bertagna X; Raffin-Sanson ML
    Rev Med Interne; 2008 Apr; 29(4):337-46. PubMed ID: 18226430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complications of Cushing's syndrome: state of the art.
    Pivonello R; Isidori AM; De Martino MC; Newell-Price J; Biller BM; Colao A
    Lancet Diabetes Endocrinol; 2016 Jul; 4(7):611-29. PubMed ID: 27177728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications.
    Isidori AM; Graziadio C; Paragliola RM; Cozzolino A; Ambrogio AG; Colao A; Corsello SM; Pivonello R;
    J Hypertens; 2015 Jan; 33(1):44-60. PubMed ID: 25415766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypercoagulability in Cushing's syndrome: From arterial to venous disease.
    St-Jean M; Lim DST; Langlois F
    Best Pract Res Clin Endocrinol Metab; 2021 Mar; 35(2):101496. PubMed ID: 33795197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cushing's syndrome of nonpituitary causes.
    Carroll TB; Findling JW
    Curr Opin Endocrinol Diabetes Obes; 2009 Aug; 16(4):308-15. PubMed ID: 19491665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic Alterations and Cardiovascular Outcomes of Cortisol Excess.
    Pivonello R; De Martino MC; Iacuaniello D; Simeoli C; Muscogiuri G; Carlomagno F; De Leo M; Cozzolino A; Colao A
    Front Horm Res; 2016; 46():54-65. PubMed ID: 27212264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease.
    Feldt-Rasmussen U; Abs R; Bengtsson BA; Bennmarker H; Bramnert M; Hernberg-Ståhl E; Monson JP; Westberg B; Wilton P; Wüster C;
    Eur J Endocrinol; 2002 Jan; 146(1):67-74. PubMed ID: 11751070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cushing's syndrome: Treatment and new therapeutic approaches.
    Ferriere A; Tabarin A
    Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101381. PubMed ID: 32035797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic Syndrome in Cushing's Syndrome Patients.
    Ferraù F; Korbonits M
    Front Horm Res; 2018; 49():85-103. PubMed ID: 29894989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nephrolithiasis in Cushing's disease: prevalence, etiopathogenesis, and modification after disease cure.
    Faggiano A; Pivonello R; Melis D; Filippella M; Di Somma C; Petretta M; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2003 May; 88(5):2076-80. PubMed ID: 12727957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypertension in patients with Cushing's disease: pathophysiology, diagnosis, and management.
    Sacerdote A; Weiss K; Tran T; Rokeya Noor B; McFarlane SI
    Curr Hypertens Rep; 2005 Jun; 7(3):212-8. PubMed ID: 15913497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subclinical Cushing's syndrome.
    Reincke M
    Endocrinol Metab Clin North Am; 2000 Mar; 29(1):43-56. PubMed ID: 10732263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for Cushing's syndrome in an era of epidemic obesity.
    Clutter WE
    Mo Med; 2011; 108(2):104-6. PubMed ID: 21568231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucocorticoid excess and hypertension.
    Baid S; Nieman LK
    Curr Hypertens Rep; 2004 Dec; 6(6):493-9. PubMed ID: 15527696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MANAGEMENT OF ENDOCRINE DISEASE: Management of Cushing's syndrome during pregnancy: solved and unsolved questions.
    Brue T; Amodru V; Castinetti F
    Eur J Endocrinol; 2018 Jun; 178(6):R259-R266. PubMed ID: 29523633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening of Cushing's syndrome in outpatients with type 2 diabetes: results of a prospective multicentric study in Italy.
    Terzolo M; Reimondo G; Chiodini I; Castello R; Giordano R; Ciccarelli E; Limone P; Crivellaro C; Martinelli I; Montini M; Disoteo O; Ambrosi B; Lanzi R; Arosio M; Senni S; Balestrieri A; Solaroli E; Madeo B; De Giovanni R; Strollo F; Battista R; Scorsone A; Giagulli VA; Collura D; Scillitani A; Cozzi R; Faustini-Fustini M; Pia A; Rinaldi R; Allasino B; Peraga G; Tassone F; Garofalo P; Papini E; Borretta G
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3467-75. PubMed ID: 22767639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.